Status of GMOs and Products
Healthcare Applications
Commercially Approved
Recombinant therapeutics approved for marketing in India
S.No. Molecules Therapeutic applications
1. Human insulin Diabetes
2. Erythropoietin Treatment of anaemia
3. Hepatitis B vaccine (recombinant surface antigen based) Immunization against Hepatitis B
4. Human growth hormone Deficiency of growth hormone in children
5. Interleukin 2 Renal cell carcinoma
6. Interleukin 11 Thrombocytopenia
7. Granulocyte Colony Stimulating Factor Chemotherapy induced neutropenia
8. Granulocyte Macrophage Colony Stimulating Factor Chemotherapy induced neutropenia
9. Interferon 2Alpha Chronic myeloid leukemia
10. Interferon 2Beta Chronic myeloid leukemia, Hepatitis B and Hepatitis C
11. Interferons Gamma Chronic granulomatous disease and Severe malignant osteopetrosis
12. Streptokinase Acute myocardial infarction
13. Tissue Plasminogen Activator Acute myocardial infarction
14. Blood factor VIII Haemophilia type A
15. Follicle stimulating hormone Reproductive disorders
16. Teriparatide (Forteo) Osteoporosis
17. Drerecogin (Xigris) alpha Severe sepsis
18. Platelet Derived Growth Factor (PDGF) Bone marrow induction and osteoblasts proliferation
19. Epidermal Growth factor (EGF) Mitogenesis and organ morphogenesis
20. Eptacogalpha (r-F VIIa) r-coagulation factor Haemorrhages, congenital or acquired hemophilia